Levetiracetam physicochemical properties and ADME parameters were incorporated from the model developed by Sinha, Karatza (14). [Table 7](#table_7) presents the drug specific parameters of levetiracetam and the values used within the healthy adult model.

The healthy PBPK model development was based on two single dose IV PK studies (1000 and 2000 mg) and two single dose oral PK studies (500 and 1000 mg) described in Sinha, Karatza (14). 

**Table 7. Physicochemical properties and ADME of caffeine for the final IV/PO model** <a id="table_7">

| **Physicochemical properties**    |                                      |
|--|--|
| Octanol:water coefficient (logP)           | -0.64 Log Units |
| Fraction unbound in plasma (f<sub>u</sub>) | 0.97 |
| Molecular weight (MW)                      | 170.21 g/mol |
| pKa                                        | Neutral |
| Water solubility                           | 1,040 mg/mL |
| **ADME**                                   |                             |
| Partition coefficient                      | Rodgers and Rowland |
| Cell permeability                          | PK-Sim Standard |
| RBC esterase concentration                 | 1 µM |
| RBC esterase K<sub>M</sub>                 | 439 µM |
| RBC esterase V<sub>max</sub>               | 8,000 pmol/min/mL |
| GFR fraction                               | 0.4 |
| Specific intestinal permeability (transcellular) | 1.84E-3 cm/min |
| **Oral absorption parameters**             |                             |
| Formulation: Tablet T<sub>50%</sub>, T<sub>90%</sub>, T<sub>100%</sub> | 5 min, 10 min, 15 min |
T<sub>50%</sub>, T<sub>90%</sub>, T<sub>100%</sub>: Time to dissolve 50%, 90%, and 100% tablet strength (14).